Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Zeigerer

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Molecular Metabolism|June 10, 2026
Hepatokines lipocalin 2 and osteopontin drive muscle atrophy in MASHAmy R Fumo, Simon I Dreher, Pauline Morigny, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2010
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanismsAkin Akinc, William Querbes, Soma De, et al.
Molecular Metabolism|April 4, 2022
Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial functionGretchen Wolff, Minako Sakurai, Amit Mhamane, et al.
The Journal of Clinical Investigation|May 15, 2026
Inhibition of ceramide synthesis ameliorates body wasting in a cancer cachexia modelPauline Morigny, Honglei Ji, Laura Cussonneau, et al.
Nature Biomedical Engineering|December 10, 2024
Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinomaAristeidis Papargyriou, Mulham Najajreh, David P Cook, et al.
Archives of Toxicology|June 29, 2019
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrationsWiebke Albrecht, Franziska Kappenberg, Tim Brecklinghaus, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Molecular Metabolism|June 10, 2026
Hepatokines lipocalin 2 and osteopontin drive muscle atrophy in MASHAmy R Fumo, Simon I Dreher, Pauline Morigny, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2010
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanismsAkin Akinc, William Querbes, Soma De, et al.
Molecular Metabolism|April 4, 2022
Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial functionGretchen Wolff, Minako Sakurai, Amit Mhamane, et al.
The Journal of Clinical Investigation|May 15, 2026
Inhibition of ceramide synthesis ameliorates body wasting in a cancer cachexia modelPauline Morigny, Honglei Ji, Laura Cussonneau, et al.
Nature Biomedical Engineering|December 10, 2024
Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinomaAristeidis Papargyriou, Mulham Najajreh, David P Cook, et al.
Archives of Toxicology|June 29, 2019
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrationsWiebke Albrecht, Franziska Kappenberg, Tim Brecklinghaus, et al.
Pageof 5